Open Access

An integrative therapeutic approach to elephantiasis nostras verrucosa: A case report

  • Authors:
    • Lawrence Chukwudi Nwabudike
    • Olimpia Buzia
    • Alina Mihaela Elisei
    • Alin Laurentiu Tatu
  • View Affiliations

  • Published online on: February 16, 2022     https://doi.org/10.3892/etm.2022.11218
  • Article Number: 289
  • Copyright: © Nwabudike et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Elephantiasis nostras is a chronic disorder that is difficult to treat. It is characterized by marked lymphedema, associated with hyperkeratosis, ulceration, deep skin folds and a cobblestone appearance of the skin. Causes include parasitic and bacterial infections, neoplasia and obesity, but numerous cases have uncertain aetiology. Treatment includes surgery and medication, which are associated with variable results. In the present study, a 72‑year old female with renal insufficiency presented with leg enlargement of 3‑4 years duration, which rendered her housebound. Examination showed massive lower limb enlargement, with typical cobblestone appearance. She was on furoseminde 80 mg/day. A diagnosis of elephantiasis nostras was made. Then, she was treated with increased furosemide from 80 to 120 mg daily and homeopathic Apocynum cannabinum, CH30 potency, t.d.s. Unavailability of corresponding fit excluded the use of compressive stockings. The patient remitted over 18 months, with limb diameters dropping from 68/46 cm (right mid‑calf/ankle) and 67/43 cm (left mid‑calf/ankle) to 64/43 cm (right mid‑calf/ankle) and 64.5/45 cm (left mid‑calf/ankle) at 6 months, 63/42 cm (right mid‑calf/ankle) and 65/41 cm (left mid‑calf/ankle) at 12 months, and 46/35 cm (right mid‑calf/ankle) and 48/36 cm (left mid‑calf/ankle) at 18 months, with improvement of skin appearance. Elephantiasis nostras is not spontaneously remitting. In this resource‑limited setting, furosemide combined with homeopathic Apocynum cannabinum has proved valuable and may be used for similar cases.
View Figures
View References

Related Articles

Journal Cover

April-2022
Volume 23 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nwabudike LC, Buzia O, Elisei AM and Tatu AL: An integrative therapeutic approach to elephantiasis nostras verrucosa: A case report. Exp Ther Med 23: 289, 2022.
APA
Nwabudike, L.C., Buzia, O., Elisei, A.M., & Tatu, A.L. (2022). An integrative therapeutic approach to elephantiasis nostras verrucosa: A case report. Experimental and Therapeutic Medicine, 23, 289. https://doi.org/10.3892/etm.2022.11218
MLA
Nwabudike, L. C., Buzia, O., Elisei, A. M., Tatu, A. L."An integrative therapeutic approach to elephantiasis nostras verrucosa: A case report". Experimental and Therapeutic Medicine 23.4 (2022): 289.
Chicago
Nwabudike, L. C., Buzia, O., Elisei, A. M., Tatu, A. L."An integrative therapeutic approach to elephantiasis nostras verrucosa: A case report". Experimental and Therapeutic Medicine 23, no. 4 (2022): 289. https://doi.org/10.3892/etm.2022.11218